18.71
price down icon0.11%   -0.02
after-market Dopo l'orario di chiusura: 18.82 0.11 +0.59%
loading
Precedente Chiudi:
$18.73
Aprire:
$18.68
Volume 24 ore:
177.92K
Relative Volume:
0.86
Capitalizzazione di mercato:
$378.72M
Reddito:
$116.88M
Utile/perdita netta:
$-25.09M
Rapporto P/E:
-133.64
EPS:
-0.14
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+0.05%
1M Prestazione:
-2.55%
6M Prestazione:
+11.24%
1 anno Prestazione:
+122.47%
Intervallo 1D:
Value
$18.24
$19.02
Intervallo di 1 settimana:
Value
$18.14
$19.79
Portata 52W:
Value
$7.4843
$29.82

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
Nome
Rigel Pharmaceuticals
Name
Telefono
650-624-1100
Name
Indirizzo
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
Dipendente
164
Name
Cinguettio
@rigelpharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
RIGL's Discussions on Twitter

Confronta RIGL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RIGL
Rigel Pharmaceuticals
18.71 378.72M 116.88M -25.09M -20.74M -0.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-04-03 Ripresa Piper Sandler Neutral
2022-06-09 Downgrade Citigroup Buy → Neutral
2022-06-08 Downgrade Cantor Fitzgerald Overweight → Neutral
2022-06-08 Downgrade Piper Sandler Overweight → Neutral
2022-03-23 Iniziato B. Riley Securities Neutral
2020-11-09 Downgrade JP Morgan Overweight → Neutral
2019-11-15 Ripresa Cantor Fitzgerald Overweight
2019-09-26 Ripresa JP Morgan Overweight
2019-03-01 Reiterato Cantor Fitzgerald Overweight
2018-08-27 Iniziato Citigroup Buy
2018-05-02 Reiterato Cantor Fitzgerald Overweight
2017-12-21 Ripresa Piper Jaffray Overweight
2017-12-15 Iniziato Cantor Fitzgerald Overweight
2017-11-06 Ripresa H.C. Wainwright Buy
2017-03-09 Reiterato H.C. Wainwright Buy
2016-08-31 Reiterato H.C. Wainwright Buy
2016-08-30 Reiterato Piper Jaffray Overweight
2016-07-13 Iniziato H.C. Wainwright Buy
2016-06-13 Iniziato Piper Jaffray Overweight
2016-04-22 Aggiornamento JP Morgan Neutral → Overweight
2013-04-08 Reiterato Stifel Buy
2012-11-29 Iniziato UBS Neutral
2012-11-06 Reiterato Oppenheimer Outperform
2012-03-26 Iniziato Canaccord Genuity Hold
2010-12-10 Downgrade MP Advisors Outperform → Market Perform
Mostra tutto

Rigel Pharmaceuticals Borsa (RIGL) Ultime notizie

pulisher
Jun 18, 2025

Recent 11% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 112% over 1 year - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Canada

Jun 14, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com

Jun 14, 2025
pulisher
Jun 11, 2025

High-grade Glioma Market Expected to Experience Major Growth by 2034, According to DelveInsight | Rigel Pharma, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Rigel Pharma To Present At Jefferies Global Healthcare Conference; Webcast At 12:50 PM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Increases Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Rigel to Present at the Jefferies Global Healthcare Conference - StreetInsider

May 29, 2025
pulisher
May 28, 2025

Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise

May 28, 2025
pulisher
May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference | RIGL Stock News - GuruFocus

May 28, 2025
pulisher
May 27, 2025

(RIGL) Proactive Strategies - news.stocktradersdaily.com

May 27, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India

May 26, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com

May 26, 2025
pulisher
May 25, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World

May 25, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 25, 2025
pulisher
May 23, 2025

Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks

May 23, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire

May 22, 2025
pulisher
May 22, 2025

Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 22, 2025
pulisher
May 18, 2025

17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LP - Defense World

May 18, 2025
pulisher
May 16, 2025

(RIGL) Investment Analysis - news.stocktradersdaily.com

May 16, 2025
pulisher
May 15, 2025

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st

May 15, 2025
pulisher
May 14, 2025

Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now? - Yahoo Finance

May 13, 2025
pulisher
May 11, 2025

Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet - MSN

May 11, 2025
pulisher
May 11, 2025

Upgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Forecasts - Yahoo Finance

May 11, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Buys 2,648 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 11, 2025
pulisher
May 11, 2025

Cantor Fitzgerald Brokers Reduce Earnings Estimates for RIGL - Defense World

May 11, 2025
pulisher
May 10, 2025

B. Riley Expects Reduced Earnings for Rigel Pharmaceuticals - Defense World

May 10, 2025
pulisher
May 10, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Earnings Estimates Rising for Rigel (RIGL): Will It Gain? - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Acquires 2,014 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 09, 2025
pulisher
May 09, 2025

Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st

May 09, 2025
pulisher
May 09, 2025

Rigel pharmaceuticals targets $200M-$210M revenue in 2025 with strong Q1 performance - MSN

May 09, 2025
pulisher
May 09, 2025

Rigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

HC Wainwright Issues Positive Outlook for RIGL Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Rigel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of “Hold” by Analysts - Defense World

May 08, 2025
pulisher
May 07, 2025

Rigel Pharmaceuticals Reports Strong Growth and Strategic Advances - TipRanks

May 07, 2025
pulisher
May 07, 2025

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (NASDAQ:RIGL) - Seeking Alpha

May 07, 2025
pulisher
May 07, 2025

Rigel Pharmaceuticals (RIGL) Price Target Raised by Cantor Fitzg - GuruFocus

May 07, 2025

Rigel Pharmaceuticals Azioni (RIGL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Rigel Pharmaceuticals Azioni (RIGL) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Schorno Dean L
EVP & Chief Financial Officer
Feb 05 '25
Sale
21.93
1,734
38,020
57,235
Santos David A
EVP, Chief Commercial Officer
Feb 04 '25
Sale
20.92
2,125
44,457
53,500
Santos David A
EVP, Chief Commercial Officer
Feb 05 '25
Sale
21.93
1,796
39,379
51,704
RODRIGUEZ RAUL R
CEO, President
Feb 04 '25
Sale
20.92
4,952
103,601
243,854
RODRIGUEZ RAUL R
CEO, President
Feb 05 '25
Sale
21.93
4,400
96,474
239,454
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Feb 04 '25
Sale
20.92
1,448
30,294
40,169
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Feb 05 '25
Sale
21.93
1,339
29,359
38,830
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):